IBDEI0J0 ; ; 09-AUG-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 12, 2016
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,24093,1,3,0)
 ;;=3^Bipolar I Disorder,Current/Recent Episode Hypomanic
 ;;^UTILITY(U,$J,358.3,24093,1,4,0)
 ;;=4^F31.0
 ;;^UTILITY(U,$J,358.3,24093,2)
 ;;=^5003494
 ;;^UTILITY(U,$J,358.3,24094,0)
 ;;=F31.71^^64^949^22
 ;;^UTILITY(U,$J,358.3,24094,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24094,1,3,0)
 ;;=3^Bipolar I Disorder,Current/Recent Episode Hypomanic,In Partial Remission
 ;;^UTILITY(U,$J,358.3,24094,1,4,0)
 ;;=4^F31.71
 ;;^UTILITY(U,$J,358.3,24094,2)
 ;;=^5003511
 ;;^UTILITY(U,$J,358.3,24095,0)
 ;;=F31.72^^64^949^21
 ;;^UTILITY(U,$J,358.3,24095,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24095,1,3,0)
 ;;=3^Bipolar I Disorder,Current/Recent Episode Hypomanic,In Full Remission
 ;;^UTILITY(U,$J,358.3,24095,1,4,0)
 ;;=4^F31.72
 ;;^UTILITY(U,$J,358.3,24095,2)
 ;;=^5003512
 ;;^UTILITY(U,$J,358.3,24096,0)
 ;;=F06.33^^64^949^3
 ;;^UTILITY(U,$J,358.3,24096,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24096,1,3,0)
 ;;=3^Bipolar & Related Disorder d/t Med Cond w/ Manic/Hypomanic-Like Episode
 ;;^UTILITY(U,$J,358.3,24096,1,4,0)
 ;;=4^F06.33
 ;;^UTILITY(U,$J,358.3,24096,2)
 ;;=^5003059
 ;;^UTILITY(U,$J,358.3,24097,0)
 ;;=F31.9^^64^949^12
 ;;^UTILITY(U,$J,358.3,24097,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24097,1,3,0)
 ;;=3^Bipolar I Disorder,Current/Recent Episode Manic,Unsp
 ;;^UTILITY(U,$J,358.3,24097,1,4,0)
 ;;=4^F31.9
 ;;^UTILITY(U,$J,358.3,24097,2)
 ;;=^331892
 ;;^UTILITY(U,$J,358.3,24098,0)
 ;;=F31.9^^64^949^19
 ;;^UTILITY(U,$J,358.3,24098,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24098,1,3,0)
 ;;=3^Bipolar I Disorder,Current/Recent Episode Depressed,Unsp
 ;;^UTILITY(U,$J,358.3,24098,1,4,0)
 ;;=4^F31.9
 ;;^UTILITY(U,$J,358.3,24098,2)
 ;;=^331892
 ;;^UTILITY(U,$J,358.3,24099,0)
 ;;=F31.89^^64^949^4
 ;;^UTILITY(U,$J,358.3,24099,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24099,1,3,0)
 ;;=3^Bipolar & Related Disorder,Other Specified
 ;;^UTILITY(U,$J,358.3,24099,1,4,0)
 ;;=4^F31.89
 ;;^UTILITY(U,$J,358.3,24099,2)
 ;;=^5003520
 ;;^UTILITY(U,$J,358.3,24100,0)
 ;;=F31.9^^64^949^5
 ;;^UTILITY(U,$J,358.3,24100,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24100,1,3,0)
 ;;=3^Bipolar & Related Disorder,Unsp
 ;;^UTILITY(U,$J,358.3,24100,1,4,0)
 ;;=4^F31.9
 ;;^UTILITY(U,$J,358.3,24100,2)
 ;;=^331892
 ;;^UTILITY(U,$J,358.3,24101,0)
 ;;=A81.00^^64^950^8
 ;;^UTILITY(U,$J,358.3,24101,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24101,1,3,0)
 ;;=3^Creutzfeldt-Jakob Disease,Unspec
 ;;^UTILITY(U,$J,358.3,24101,1,4,0)
 ;;=4^A81.00
 ;;^UTILITY(U,$J,358.3,24101,2)
 ;;=^5000409
 ;;^UTILITY(U,$J,358.3,24102,0)
 ;;=A81.09^^64^950^7
 ;;^UTILITY(U,$J,358.3,24102,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24102,1,3,0)
 ;;=3^Creutzfeldt-Jakob Disease,Other
 ;;^UTILITY(U,$J,358.3,24102,1,4,0)
 ;;=4^A81.09
 ;;^UTILITY(U,$J,358.3,24102,2)
 ;;=^5000410
 ;;^UTILITY(U,$J,358.3,24103,0)
 ;;=A81.2^^64^950^72
 ;;^UTILITY(U,$J,358.3,24103,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24103,1,3,0)
 ;;=3^Progressive Multifocal Leukoencephalopathy
 ;;^UTILITY(U,$J,358.3,24103,1,4,0)
 ;;=4^A81.2
 ;;^UTILITY(U,$J,358.3,24103,2)
 ;;=^5000411
 ;;^UTILITY(U,$J,358.3,24104,0)
 ;;=F01.50^^64^950^46
 ;;^UTILITY(U,$J,358.3,24104,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24104,1,3,0)
 ;;=3^Major Neurocog D/O d/t Prob VASCULAR DISEASE w/o Behav Disturb
 ;;^UTILITY(U,$J,358.3,24104,1,4,0)
 ;;=4^F01.50
 ;;^UTILITY(U,$J,358.3,24104,2)
 ;;=^5003046
 ;;^UTILITY(U,$J,358.3,24105,0)
 ;;=F01.51^^64^950^47
 ;;^UTILITY(U,$J,358.3,24105,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24105,1,3,0)
 ;;=3^Major Neurocog D/O d/t Prob VASCULAR DISEASE w/ Behav Disturb
 ;;^UTILITY(U,$J,358.3,24105,1,4,0)
 ;;=4^F01.51
 ;;^UTILITY(U,$J,358.3,24105,2)
 ;;=^5003047
 ;;^UTILITY(U,$J,358.3,24106,0)
 ;;=F02.80^^64^950^34
 ;;^UTILITY(U,$J,358.3,24106,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24106,1,3,0)
 ;;=3^Major Neurocog D/O d/t Poss ALZHEIMER'S DISEASE w/o Behav Disturb
 ;;^UTILITY(U,$J,358.3,24106,1,4,0)
 ;;=4^F02.80
 ;;^UTILITY(U,$J,358.3,24106,2)
 ;;=^5003048
 ;;^UTILITY(U,$J,358.3,24107,0)
 ;;=F02.81^^64^950^35
 ;;^UTILITY(U,$J,358.3,24107,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24107,1,3,0)
 ;;=3^Major Neurocog D/O d/t Poss ALZHEIMER'S DISEASE w/ Behav Disturb
 ;;^UTILITY(U,$J,358.3,24107,1,4,0)
 ;;=4^F02.81
 ;;^UTILITY(U,$J,358.3,24107,2)
 ;;=^5003049
 ;;^UTILITY(U,$J,358.3,24108,0)
 ;;=G30.9^^64^950^4
 ;;^UTILITY(U,$J,358.3,24108,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24108,1,3,0)
 ;;=3^Alzheimer's Disease,Unspec
 ;;^UTILITY(U,$J,358.3,24108,1,4,0)
 ;;=4^G30.9
 ;;^UTILITY(U,$J,358.3,24108,2)
 ;;=^5003808
 ;;^UTILITY(U,$J,358.3,24109,0)
 ;;=G31.01^^64^950^70
 ;;^UTILITY(U,$J,358.3,24109,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24109,1,3,0)
 ;;=3^Pick's Disease
 ;;^UTILITY(U,$J,358.3,24109,1,4,0)
 ;;=4^G31.01
 ;;^UTILITY(U,$J,358.3,24109,2)
 ;;=^329915
 ;;^UTILITY(U,$J,358.3,24110,0)
 ;;=G94.^^64^950^6
 ;;^UTILITY(U,$J,358.3,24110,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24110,1,3,0)
 ;;=3^Brain Disorders in Diseases Classified Elsewhere NEC
 ;;^UTILITY(U,$J,358.3,24110,1,4,0)
 ;;=4^G94.
 ;;^UTILITY(U,$J,358.3,24110,2)
 ;;=^5004187
 ;;^UTILITY(U,$J,358.3,24111,0)
 ;;=G31.83^^64^950^18
 ;;^UTILITY(U,$J,358.3,24111,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24111,1,3,0)
 ;;=3^Dementia w/ Lewy Bodies
 ;;^UTILITY(U,$J,358.3,24111,1,4,0)
 ;;=4^G31.83
 ;;^UTILITY(U,$J,358.3,24111,2)
 ;;=^329888
 ;;^UTILITY(U,$J,358.3,24112,0)
 ;;=G31.89^^64^950^11
 ;;^UTILITY(U,$J,358.3,24112,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24112,1,3,0)
 ;;=3^Degenerative Diseases of Nervous System NEC
 ;;^UTILITY(U,$J,358.3,24112,1,4,0)
 ;;=4^G31.89
 ;;^UTILITY(U,$J,358.3,24112,2)
 ;;=^5003814
 ;;^UTILITY(U,$J,358.3,24113,0)
 ;;=G31.9^^64^950^12
 ;;^UTILITY(U,$J,358.3,24113,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24113,1,3,0)
 ;;=3^Degenerative Diseases of Nervous System,Unspec
 ;;^UTILITY(U,$J,358.3,24113,1,4,0)
 ;;=4^G31.9
 ;;^UTILITY(U,$J,358.3,24113,2)
 ;;=^5003815
 ;;^UTILITY(U,$J,358.3,24114,0)
 ;;=G23.8^^64^950^10
 ;;^UTILITY(U,$J,358.3,24114,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24114,1,3,0)
 ;;=3^Degenerative Diseases of Basal Ganglia NEC
 ;;^UTILITY(U,$J,358.3,24114,1,4,0)
 ;;=4^G23.8
 ;;^UTILITY(U,$J,358.3,24114,2)
 ;;=^5003782
 ;;^UTILITY(U,$J,358.3,24115,0)
 ;;=G30.0^^64^950^2
 ;;^UTILITY(U,$J,358.3,24115,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24115,1,3,0)
 ;;=3^Alzheimer's Disease w/ Early Onset
 ;;^UTILITY(U,$J,358.3,24115,1,4,0)
 ;;=4^G30.0
 ;;^UTILITY(U,$J,358.3,24115,2)
 ;;=^5003805
 ;;^UTILITY(U,$J,358.3,24116,0)
 ;;=G30.1^^64^950^3
 ;;^UTILITY(U,$J,358.3,24116,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24116,1,3,0)
 ;;=3^Alzheimer's Disease w/ Late Onset
 ;;^UTILITY(U,$J,358.3,24116,1,4,0)
 ;;=4^G30.1
 ;;^UTILITY(U,$J,358.3,24116,2)
 ;;=^5003806
 ;;^UTILITY(U,$J,358.3,24117,0)
 ;;=B20.^^64^950^21
 ;;^UTILITY(U,$J,358.3,24117,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24117,1,3,0)
 ;;=3^HIV Infection
 ;;^UTILITY(U,$J,358.3,24117,1,4,0)
 ;;=4^B20.
 ;;^UTILITY(U,$J,358.3,24117,2)
 ;;=^5000555^
 ;;^UTILITY(U,$J,358.3,24118,0)
 ;;=G10.^^64^950^22
 ;;^UTILITY(U,$J,358.3,24118,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24118,1,3,0)
 ;;=3^Huntington's Disease
 ;;^UTILITY(U,$J,358.3,24118,1,4,0)
 ;;=4^G10.
 ;;^UTILITY(U,$J,358.3,24118,2)
 ;;=^5003751^
 ;;^UTILITY(U,$J,358.3,24119,0)
 ;;=G30.8^^64^950^1
 ;;^UTILITY(U,$J,358.3,24119,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24119,1,3,0)
 ;;=3^Alzheimer's Disease NEC
 ;;^UTILITY(U,$J,358.3,24119,1,4,0)
 ;;=4^G30.8
 ;;^UTILITY(U,$J,358.3,24119,2)
 ;;=^5003807
 ;;^UTILITY(U,$J,358.3,24120,0)
 ;;=A81.89^^64^950^5
 ;;^UTILITY(U,$J,358.3,24120,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24120,1,3,0)
 ;;=3^Atypical Virus Infections of CNS NEC
 ;;^UTILITY(U,$J,358.3,24120,1,4,0)
 ;;=4^A81.89
 ;;^UTILITY(U,$J,358.3,24120,2)
 ;;=^5000413
 ;;^UTILITY(U,$J,358.3,24121,0)
 ;;=G20.^^64^950^69
 ;;^UTILITY(U,$J,358.3,24121,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24121,1,3,0)
 ;;=3^Parkinson's Disease
 ;;^UTILITY(U,$J,358.3,24121,1,4,0)
 ;;=4^G20.
 ;;^UTILITY(U,$J,358.3,24121,2)
 ;;=^5003770^
 ;;^UTILITY(U,$J,358.3,24122,0)
 ;;=G23.1^^64^950^73
 ;;^UTILITY(U,$J,358.3,24122,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24122,1,3,0)
 ;;=3^Progressive Supranuclear Ophthalmoplegia Palsy
 ;;^UTILITY(U,$J,358.3,24122,1,4,0)
 ;;=4^G23.1
 ;;^UTILITY(U,$J,358.3,24122,2)
 ;;=^5003780
 ;;^UTILITY(U,$J,358.3,24123,0)
 ;;=F03.91^^64^950^17
 ;;^UTILITY(U,$J,358.3,24123,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24123,1,3,0)
 ;;=3^Dementia w/ Behavioral Disturbance,Unspec
 ;;^UTILITY(U,$J,358.3,24123,1,4,0)
 ;;=4^F03.91
 ;;^UTILITY(U,$J,358.3,24123,2)
 ;;=^5133350
 ;;^UTILITY(U,$J,358.3,24124,0)
 ;;=F03.90^^64^950^19
 ;;^UTILITY(U,$J,358.3,24124,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24124,1,3,0)
 ;;=3^Dementia w/o Behavioral Disturbance,Unspec
 ;;^UTILITY(U,$J,358.3,24124,1,4,0)
 ;;=4^F03.90
 ;;^UTILITY(U,$J,358.3,24124,2)
 ;;=^5003050
 ;;^UTILITY(U,$J,358.3,24125,0)
 ;;=F02.81^^64^950^40
 ;;^UTILITY(U,$J,358.3,24125,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24125,1,3,0)
 ;;=3^Major Neurocog D/O d/t Prob ALZHEIMER'S DISEASE w/ Behav Disturb
 ;;^UTILITY(U,$J,358.3,24125,1,4,0)
 ;;=4^F02.81
 ;;^UTILITY(U,$J,358.3,24125,2)
 ;;=^5003049
 ;;^UTILITY(U,$J,358.3,24126,0)
 ;;=F02.80^^64^950^41
 ;;^UTILITY(U,$J,358.3,24126,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24126,1,3,0)
 ;;=3^Major Neurocog D/O d/t Prob ALZHEIMER'S DISEASE w/o Behav Disturb
 ;;^UTILITY(U,$J,358.3,24126,1,4,0)
 ;;=4^F02.80
 ;;^UTILITY(U,$J,358.3,24126,2)
 ;;=^5003048
 ;;^UTILITY(U,$J,358.3,24127,0)
 ;;=G31.84^^64^950^56
 ;;^UTILITY(U,$J,358.3,24127,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24127,1,3,0)
 ;;=3^Mild Neurocog D/O d/t ALZHEIMER'S DISEASE
 ;;^UTILITY(U,$J,358.3,24127,1,4,0)
 ;;=4^G31.84
